The Effect of Sertindole on Sensory Gating and Cognition in Schizophrenic Patients.
Phase of Trial: Phase II
Latest Information Update: 14 Sep 2012
At a glance
- Drugs Sertindole (Primary) ; Risperidone
- Indications Schizophrenia
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 01 Aug 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 19 Sep 2011 Planned end date changed from 1 Aug 2011 to 1 Aug 2012 as reported by ClinicalTrials.gov.